Implementation of the ThinPrep® imaging system in a high-volume metropolitan laboratory

Diagnostic Cytopathology

Volumn 35, Issue 4, 2007, Pages 213-217

  Miller, Fern S ^a,b   Nagel, Lynn E ^a   Kenny Moynihan, Mary B ^a  

^a Metropolitan Pathologists PC   (United States)

^b Metropolitan Pathologists   (United States)

Author keywords

Cervical screening; Computer imaging; Computer assisted cytology; ThinPrep Pap Test

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER CYTODIAGNOSIS; CANCER SCREENING; COMPUTER ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VALIDATION PROCESS; ARTICLE; DIAGNOSTIC IMAGING; IMAGE PROCESSING; LABORATORY DIAGNOSIS; METHODOLOGY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR; VAGINA SMEAR; VALIDATION STUDY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSTIC IMAGING; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34047111290     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20627     Document Type: Review

References (16)

1. Allen K. Cytotechnologist shortage harms patients' health. ASCT News 2002;4:33-35.
2. Dawson A. Can we change the way we screen? The ThinPrep Imaging System. Cancer Cytopathol 2004;102:340-344.
3. Wilbur DC, Parker EM, Foti JA. Location-guided screening of liquid-based cervical cytology specimens: A potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial. Am J Clin Pathol 2002;118:399-407.
4. Miller F, Nagel L, Kenny-Moynihan M. Comparison of manual and imaging-directed screening of the ThinPrep Pap Test in a large metropolitan cytology practice. Acta Cytol 2004;48:701-702(abstract).
5. College of American Pathologists (CAP), Cytopathology Checklist: Revised 10/06/2005.
6. U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Centers for Disease Control and Prevention: 42 CFR part 493, Medicare, Medicaid, and CLIA Programs; Laboratory Requirements Relating to Quality Systems and Certain Personnel Qualifications; Final Rule: Federal Register January 24, 2003;1036.
7. ThinPrep® Imaging System Implementation Program Manual. 2004, Rev. A.
8. ThinPrep® Stain User's Manual. 2002; sec. 1.1-1.7.
9. ThinPrep® Review Scope Operator's Manual. 2002; sec. 3.1-3.24.
10. Solomon D, Nayar R. The Bethesda System for reporting cervical cytology: Definitions, criteria, and explanatory notes, 2nd ed. New York: Springer-Verlag; 2004.
11. Bernard R. Fundamentals of biostatistics, 3rd ed. Boston: PWS-Kent; 1990.
12. Digene HPV Test Hybrid Capture® II Laboratory Set-up Manual, 1999.
13. Sherman M, Lorincz A, Scott D, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 2003:95:46-52.
14. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
15. Biscotti C, Dawson A, Dziura B, et al. Assisted primary screening using the automated ThinPrep Imaging System. Am J Clin Pathol 2005;123:281-287.
16. Miller F, Nagel L, Kenny-Moynihan M. Validation of ThinPrep Imaging System assisted screening compared to manual screening of ThinPrep Pap tests. Acta Cytol 2004;48:701(abstract).